Chicago Partners Investment Group’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$555K Buy
2,890
+277
+11% +$57.4K 0.01% 933
2026
Q1
$580K Buy
2,613
+1,154
+79% +$288K 0.01% 801
2025
Q4
$368K Sell
1,459
-70
-5% -$17.9K 0.01% 924
2025
Q3
$392K Buy
1,529
+269
+21% +$73.5K 0.01% 824
2025
Q2
$344K Buy
1,260
+167
+15% +$39.8K 0.01% 775
2025
Q1
$267K Sell
1,093
-345
-24% -$80.5K 0.01% 737
2024
Q4
$340K Buy
+1,438
New +$346K 0.01% 616

Other funds holding RMD

Chicago Partners Investment Group's RMD Position: Q2 2026 in Review

Chicago Partners Investment Group increased its ResMed (RMD) stake by 11% in Q2 2026, buying an estimated $57.4K and bringing the position to 2,890 shares worth $555K. The position accounts for 0.01% of the portfolio, ranked #933.

Chicago Partners Investment Group first reported a position in RMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $580K in Q1 2026. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Chicago Partners Investment Group held 2,890 shares of ResMed worth $555K as of Q2 2026.
  • Chicago Partners Investment Group bought 277 ResMed shares in Q2 2026, an estimated $57.4K.
  • ResMed made up 0.01% of Chicago Partners Investment Group's portfolio in Q2 2026, its #933 holding.
  • Chicago Partners Investment Group first reported a position in ResMed in Q4 2024 and has held it in 7 quarters since.
  • Chicago Partners Investment Group's ResMed position peaked at $580K in Q1 2026.
  • 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.